N-Acetyl Semax Amidate (NA-Semax-A) is a synthetic heptapeptide derivative of adrenocorticotropic hormone ACTH(4-10) engineered with N-terminal acetylation and C-terminal amidation. In preclinical laboratory settings, na semax amidate research focuses on its enhanced enzymatic stability, neurotrophic signaling modulation, BDNF-pathway gene expression, and cellular resistance to oxidative and hypoxic stress.
N-Acetyl Semax Amidate (NA-Semax-A) is a synthetic heptapeptide derivative of adrenocorticotropic hormone ACTH(4-10) engineered with N-terminal acetylation and C-terminal amidation. In preclinical laboratory settings, na semax amidate research focuses on its enhanced enzymatic stability, neurotrophic signaling modulation, BDNF-pathway gene expression, and cellular resistance to oxidative and hypoxic stress.
N-Acetyl Semax Amidate represents an advanced modification of the original synthetic peptide Semax, which itself was derived from the fragment ACTH(4-10) (Met-Glu-His-Phe-Pro-Gly-Pro). In primary sequence design, the wild-type ACTH fragment exhibits rapid enzymatic degradation by circulating endopeptidases and aminopeptidases. To overcome these biochemical kinetic limitations in experimental settings, researchers introduced two strategic terminal modifications: N-terminal acetylation and C-terminal amidation.
The addition of an acetyl group at the N-terminus shields the peptide chain from cleavage by aminopeptidases, while amidation of the C-terminus protects against carboxypeptidase activity. These structural refinements significantly extend the half-life of the compound in culture media and tissue homogenates. Researchers interested in structural modifications across regulatory peptides can explore our complete directory of all peptides for comparative biochemical study.
In analytical assays, NA-Semax-A demonstrates altered lipophilicity and modified hydrogen-bonding capacity compared to its un-acetylated parent peptide. These physical properties are crucial when designing in vitro transport assays or evaluating peptidase resistance across isolated tissue preparations.
A central focal point of na semax amidate research is its capacity to influence neurotrophic signaling cascades in neuronal cell lines and isolated brain tissue samples. Preclinical studies suggest that exposure to ACTH(4-10) derivatives stimulates the transcriptional upregulation of Brain-Derived Neurotrophic Factor (BDNF) and its cognate receptor, tropomyosin receptor kinase B (TrkB).
In vitro assays using primary hippocampal and cortical neuron cultures show that application of N-Acetyl Semax Amidate leads to a rapid increase in BDNF mRNA expression, followed by elevated intracellular levels of mature BDNF protein. This neurotrophic surge triggers downstream signaling cascades, including the MAPK/ERK and PI3K/Akt pathways, which are integral to cellular survival, neurite outgrowth, and synaptic plasticity mechanisms.
Furthermore, experimental models investigating neuroprotective activity suggest that BDNF activation via NA-Semax-A treatment helps preserve cellular viability under conditions of serum deprivation or excitotoxic glutamate exposure. For researchers conducting detailed mechanistic studies on trophic factors, ordering verified NA Semax Amidate ensures consistent baseline activity for cellular assays.
Beyond baseline neurotrophic expression, preclinical research extensively evaluates NA-Semax-A under simulated pathophysiological stress, such as hypoxia and ischemia. Rodent models of focal cerebral ischemia have demonstrated that administration of ACTH(4-10) structural analogs modulates the acute inflammatory response by altering cytokine profiles, specifically suppressing pro-inflammatory cytokines like TNF-alpha and IL-1 beta while maintaining anti-inflammatory signals.
In vascular endothelial cell cultures, researchers have observed that NA-Semax-A influences trophic vascular signaling by regulating vascular endothelial growth factor (VEGF) expression. Under hypoxic incubation, cell cultures treated with the amidated derivative retain greater capillary-like tube formation and structural integrity compared to untreated control groups.
These cellular responses highlight the compound's multifaceted utility in preclinical research focusing on vascular protection, oxidative stress mitigation, and cellular homeostasis during metabolic disruption.
When designing comparative experimental protocols, investigators frequently evaluate structural variations within the ACTH and neuropeptide families to isolate specific kinetic and pharmacodynamic parameters. The modifications present in NA-Semax-A distinguish it from baseline formulations, altering both binding kinetics and enzymatic resistance in physiological buffers.
In parallel studies, researchers often contrast the properties of Semax with its intermediate modification N-Acetyl Semax and the fully modified amidated variant. While unmodified Semax offers rapid onset in short-duration in vitro assays, N-Acetyl Semax provides moderate resistance to degradation. The dual-capped N-Acetyl Semax Amidate demonstrates maximum proteolytic stability, making it the preferred subject for extended-duration cell culture protocols. Additionally, investigators evaluating cognitive and anxiolytic peptide pathways frequently cross-reference these findings with Selank and N-Acetyl Selank Amidate.
A thorough breakdown of structural variations, receptor cross-talk, and experimental methodologies can be found in our comprehensive Semax vs. Selank preclinical comparison resource.
Proper handling and storage procedures are paramount to maintaining the structural integrity and biological activity of high-purity peptides. NA-Semax-A is supplied as a lyophilized (freeze-dried) powder to maximize shelf stability during transport and storage.
Upon receipt, lyophilized vials should be stored immediately in a freezer at -20°C or -80°C for long-term stability. Prior to reconstitution, vials must be allowed to equilibrate to room temperature to prevent condensation from forming inside the container, which can lead to premature hydrolysis.
For reconstitution in laboratory protocols, sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4) should be added slowly down the inner glass wall of the vial. The vial should be gently swirled rather than vigorously shaken to prevent peptide aggregation or mechanical shear stress. Once reconstituted, liquid aliquots should be stored at 2°C to 8°C for short-term use or frozen at -80°C to avoid repeated freeze-thaw cycles. Detailed step-by-step math and liquid measurement guides are accessible via our peptide reconstitution calculator guide.
Reproducibility in scientific literature requires uncompromising raw material purity. Impurities such as truncated peptide fragments, residual coupling reagents, or heavy metals can confound cell culture assays and yield false-positive or false-negative results.
Rigorous verification of NA-Semax-A requires a two-tiered analytical approach: High-Performance Liquid Chromatography (HPLC) to confirm purity percentage and Electrospray Ionization Mass Spectrometry (ESI-MS) to verify exact molecular weight. High-grade research material should consistently demonstrate a minimum purity of 98% via Reversed-Phase HPLC (RP-HPLC).
Researchers should always verify that their supplier provides lot-specific Certificate of Analysis (COA) documents that include full chromatograms and mass spectra rather than generic text statements. You can explore complete analytical methods and assay documentation within our centralized PX1 research library.
For researchers conducting primary cell culture, microglial activation assays, or in vivo animal studies, endotoxin contamination presents a major confounding variable. Bacterial endotoxins (lipopolysaccharides, LPS) trigger Toll-like receptor 4 (TLR4) activation, inducing artificial inflammatory responses that invalidate baseline neuro-immunology data.
PX1 Research subjects every lot of peptide material to quantitative Limulus Amebocyte Lysate (LAL) or recombinant Factor C testing to guarantee endotoxin levels remain strictly below rigorous research thresholds (<0.5 EU/mg). Maintaining ultra-low endotoxin specifications ensures that cellular responses observed during experiments are entirely attributable to the test compound rather than immunogenic contaminants.
PX1 Research is dedicated to supplying the scientific community with reference-standard compounds produced under strict quality control protocols. All peptides offered by PX1 Research are manufactured in state-of-the-art, GMP-compliant facilities within the USA and tested by independent ISO 17025 accredited analytical laboratories.
We maintain total transparency by publishing lot-specific third-party COAs featuring complete HPLC and MS data for every batch. To support time-sensitive laboratory schedules, orders are dispatched with same-day shipping Monday through Friday from our centralized logistics hubs in California and Arizona.
Principal investigators and institutional procurement officers seeking reliable supply agreements or bulk material pricing for high-throughput screening can submit inquiries through our dedicated wholesale laboratory portal.
What is N-Acetyl Semax Amidate used for in laboratory research?
N-Acetyl Semax Amidate is used exclusively in preclinical laboratory research to study neurotrophic factor expression (such as BDNF and TrkB), peptidase resistance, neuroprotective mechanisms during hypoxic stress, and central nervous system signaling pathways.
How do N-terminal acetylation and C-terminal amidation modify Semax stability?
N-terminal acetylation protects the peptide chain from cleavage by aminopeptidases, while C-terminal amidation prevents degradation by carboxypeptidases. Together, these modifications extend the enzymatic half-life of the compound in culture media and biological samples.
What methods are used to verify the purity of NA-Semax-A at PX1 Research?
PX1 Research verifies compound purity using Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm >98% purity and Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm exact molecular mass. Every lot is also tested for endotoxin levels via LAL assays.
How should lyophilized NA-Semax-A be stored upon arrival?
Lyophilized powder should be stored at -20°C or -80°C in a dry freezer away from light. Desiccant should be kept with the vial to protect against ambient moisture.
What diluents are recommended for reconstituting NA-Semax-A for cell culture assays?
Reconstitution is typically performed using sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4) depending on the requirements of the downstream in vitro or analytical assay.
Is N-Acetyl Semax Amidate approved for human consumption or clinical use?
No. N-Acetyl Semax Amidate is strictly a research chemical designated for laboratory, in vitro, and preclinical experimental use only. It is not for human or animal therapeutic, clinical, or diagnostic use.
What are the endotoxin limits for PX1 Research peptides?
PX1 Research enforces strict endotoxin limits, ensuring levels remain under 0.5 EU/mg as measured by accredited third-party LAL testing to prevent background inflammatory noise in cellular models.
Where are PX1 Research peptides manufactured and shipped from?
All PX1 Research compounds are manufactured in USA-based GMP-compliant facilities and shipped directly from our inventory centers located in California and Arizona with same-day dispatch Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.